TALS: SEC Form 4 filed by Talaris Therapeutics Inc.

Historical context for TALS

Earlier insider filings at TALS

• Mar 7, 2023SEC Form 4: Ildstad Suzanne sold $13,992 worth of shares (6,806 units at $2.06), decreasing direct ownership by 0.22% to 3,064,560 units
• Mar 2, 2023SEC Form 4: Ildstad Suzanne sold $59 worth of shares (29 units at $2.05), decreasing direct ownership by 0.00% to 3,071,366 units
• Feb 23, 2023SEC Form 4: Ildstad Suzanne sold $7,185 worth of shares (3,500 units at $2.05), decreasing direct ownership by 0.11% to 3,071,395 units
• Feb 21, 2023SEC Form 4: Ildstad Suzanne sold $13,446 worth of shares (6,551 units at $2.05), decreasing direct ownership by 0.21% to 3,074,895 units
• Feb 3, 2023SEC Form 4 filed by Zdanowski Michael

Keep researching TALS

• TALS insider tradesEvery buy and sale reported by Talaris Therapeutics Inc. officers, directors and large holders.
• What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
• Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
• Insider trading trackerThe latest insider buys and sales across every stock.